Jalaja Potluri
Jalaja Potluri publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.
- World rank
- #102,691 of 7,710,434 ranked researchers
- Rank in United States
- #39,265 of 1,627,098
- Works
- 163
- Citations
- 10k
- Citations per work
- 64.2
What does Jalaja Potluri research?
Jalaja Potluri's work is mostly in Medicine (75%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences12275.0%
- Medicine12275.0%
- Everything else2314.2%
- Life Sciences1810.8%
- 1Hematology43% of their works
- 2Genetics18% of their works
- 3Molecular Biology11% of their works
- 4Oncology7% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Histone Deacetylase Inhibitors Research
- Neutropenia and Cancer Infections
- Acute Lymphoblastic Leukemia research
Which keywords describe Jalaja Potluri's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Minimal Residual Disease, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- Childhood Cancer
- Febrile Neutropenia
- Histone Deacetylases
- International Myeloma Working Group
- Myelofibrosis
- Genomic Aberrations
- Imatinib
- Minimal Residual Disease
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- BCR-ABL
- Chronic Lymphocytic Leukemia
- JAK2 Mutation
- Diagnosis Criteria
- HDAC Inhibitors
- Antimicrobial Agents
- Acute Lymphoblastic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors1283 topics
- AML831 topic
- Acute Myeloid Leukemia831 topic
- Minimal Residual Disease382 topics
- BCR-ABL351 topic
- Imatinib351 topic
- Chronic Lymphocytic Leukemia311 topic
- Genomic Aberrations311 topic
- JAK2 Mutation311 topic
- Myelofibrosis311 topic
- Diagnosis Criteria241 topic
- International Myeloma Working Group241 topic
- HDAC Inhibitors201 topic
- Histone Deacetylases201 topic
- Antimicrobial Agents171 topic
- Febrile Neutropenia171 topic
- Acute Lymphoblastic Leukemia141 topic
- Childhood Cancer141 topic
Where does Jalaja Potluri work?
Jalaja Potluri's main affiliation in the publication record is AbbVie (United States), United States.
How many publications and citations does Jalaja Potluri have?
OpenAlex counts 163 works and 10,470 citations for Jalaja Potluri, an h-index of 34, ranking #102,691 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jalaja Potluri. Posts are plain text and can be reported.